...
首页> 外文期刊>Drug Design, Development and Therapy >Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems
【24h】

Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems

机译:曲马多与三种5-HT 3 受体拮抗剂在聚烯烃包装袋中的稳定性,用于患者控制的给药系统

获取原文
           

摘要

Background: Mixing 5-hydroxytryptamine-3 (5-HT3) receptor antagonists with patient-controlled analgesia (PCA) solutions of tramadol has been shown to decrease the incidence of nausea and vomiting associated with the use of tramadol PCA for postoperative pain. However, such mixtures are not commercially available, and the stability of the drug combinations has not been duly studied. The study aimed to evaluate the stability of tramadol with three 5-HT3 receptor antagonists in 0.9% sodium chloride injection for PCA administration. Materials and methods: Test samples were prepared by adding 1,000?mg tramadol hydrochloride, 8?mg ondansetron hydrochloride, and 6?mg granisetron hydrochloride or 5?mg tropisetron hydrochloride to 100?mL of 0.9% sodium chloride injection in polyolefin bags. The samples were prepared in triplicates, stored at either 25°C or 4°C for 14 days, and assessed using the following compatibility parameters: precipitation, cloudiness, discoloration, and pH. Chemical stability was also determined using a validated high-pressure liquid chromatography method. Results: All of the mixtures were clear and colorless throughout the initial observation period. No change in the concentration of tramadol hydrochloride occurred with any of the 5-HT3 receptor antagonists during the 14?days. Similarly, little or no loss of the 5-HT3 receptor antagonists occurred over the 14-day period. Conclusion: Our results suggest that mixtures of tramadol hydrochloride, ondansetron hydrochloride, granisetron hydrochloride, or tropisetron hydrochloride in 0.9% sodium chloride injection were physically and chemically stable for 14?days when stored in polyolefin bags at both 4°C and 25°C.
机译:背景:已证明将5-羟色胺3(5-HT 3 )受体拮抗剂与曲马多的患者自控镇痛(PCA)溶液混合使用可减少与使用该药物相关的恶心和呕吐的发生率。曲马多PCA可减轻术后疼痛。然而,此类混合物不可商购,并且尚未对药物组合的稳定性进行适当的研究。该研究旨在评估曲马多与三种5-HT 3 受体拮抗剂在0.9%氯化钠注射液中给予PCA的稳定性。材料和方法:通过将1000?mg盐酸曲马多,8?mg恩丹西酮盐酸盐和6?mg盐酸格拉司琼或5?mg托洛司琼盐酸盐加到100mL装在聚烯烃袋中的0.9mL氯化钠溶液中来制备测试样品。样品一式三份制备,在25°C或4°C下保存14天,并使用以下相容性参数进行评估:沉淀,浑浊,变色和pH。还使用经过验证的高压液相色谱法确定化学稳定性。结果:在最初的观察期内,所有混合物均为透明无色。在14天中,任何5-HT 3 受体拮抗剂的盐酸曲马多的浓度均未发生变化。同样,在14天的时间内,5-HT 3 受体拮抗剂几乎没有损失。结论:我们的结果表明,在4%C和25°C的聚烯烃袋中储存0.9%氯化钠注射液中的曲马多盐酸盐,盐酸恩丹西酮,盐酸格拉司琼或盐酸托非司琼的混合物在物理和化学上稳定14天。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号